These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 25198489

  • 1. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM, Shivaraju A, Schneider S, Krapf S, Oertel F, Burgdorf C, Ott I, Sumer C, Kastrati A, von Scheidt W, Thilo C.
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W, Grossmann B, Geisler T, Steeg M, Droppa M, Jorbenadze R, Haap M, Gawaz M, Fateh-Moghadam S.
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [Abstract] [Full Text] [Related]

  • 3. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H.
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [Abstract] [Full Text] [Related]

  • 4. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M, Rodés-Cabau J, Urena M, DeLarochelliere R, Dumont E, Masson JB, Willson AB, Binder RK, Toggweiler S, Leipsic J, Wood DA, Webb JG.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):664-70. PubMed ID: 22744829
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial.
    Binder RK, Webb JG, Willson AB, Urena M, Hansson NC, Norgaard BL, Pibarot P, Barbanti M, Larose E, Freeman M, Dumont E, Thompson C, Wheeler M, Moss RR, Yang TH, Pasian S, Hague CJ, Nguyen G, Raju R, Toggweiler S, Min JK, Wood DA, Rodés-Cabau J, Leipsic J.
    J Am Coll Cardiol; 2013 Jul 30; 62(5):431-8. PubMed ID: 23684679
    [Abstract] [Full Text] [Related]

  • 7. The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.
    Spargias K, Toutouzas K, Chrissoheris M, Synetos A, Halapas A, Paizis I, Latsios G, Stathogiannis K, Papametzelopoulos S, Zanos S, Pavlides G, Zacharoulis A, Antoniades A, Stefanadis C.
    Hellenic J Cardiol; 2013 Jul 30; 54(1):18-24. PubMed ID: 23340125
    [Abstract] [Full Text] [Related]

  • 8. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA, Singh V, O'Neill BP, Alfonso CE, Bilsker MS, Martinez Clark P, Williams D, Cohen MG, Heldman AW, O'Neill WW.
    Catheter Cardiovasc Interv; 2013 Aug 01; 82(2):300-11. PubMed ID: 23580318
    [Abstract] [Full Text] [Related]

  • 9. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC, Pawar S, Minutello RM, Horn EM, Skubas NJ, Devereux RB, Salemi A.
    J Thorac Cardiovasc Surg; 2015 Nov 01; 150(5):1111-7. PubMed ID: 26277463
    [Abstract] [Full Text] [Related]

  • 10. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, Leshnower BG, Guyton RA, Kanitkar M, Keegan P, Simone A, Stewart JP, Ghasemzadeh N, Block P, Thourani VH.
    JACC Cardiovasc Interv; 2014 Aug 01; 7(8):898-904. PubMed ID: 25086843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.
    J Am Coll Cardiol; 2014 Mar 25; 63(11):1100-9. PubMed ID: 24291283
    [Abstract] [Full Text] [Related]

  • 13. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E, Martín P, Hernández R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C.
    Catheter Cardiovasc Interv; 2014 Apr 01; 83(5):791-5. PubMed ID: 24285561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
    Fateh-Moghadam S, Voesch S, Htun P, Jorbenadze R, Geisler T, Gawaz M, Bocksch W.
    Thromb Haemost; 2016 Jan 01; 115(1):109-16. PubMed ID: 26311528
    [Abstract] [Full Text] [Related]

  • 16. Transcatheter Aortic Valve Replacement Using Transaortic Access: Experience From the Multicenter, Multinational, Prospective ROUTE Registry.
    Bapat V, Frank D, Cocchieri R, Jagielak D, Bonaros N, Aiello M, Lapeze J, Laine M, Chocron S, Muir D, Eichinger W, Thielmann M, Labrousse L, Rein KA, Verhoye JP, Gerosa G, Baumbach H, Bramlage P, Deutsch C, Thoenes M, Romano M.
    JACC Cardiovasc Interv; 2016 Sep 12; 9(17):1815-22. PubMed ID: 27609256
    [Abstract] [Full Text] [Related]

  • 17. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK, Minha S, Barbash IM, Torguson R, Magalhaes MA, Okubagzi P, Loh JP, Chen F, Satler LF, Pichard AD, Waksman R.
    Am J Cardiol; 2014 Jan 15; 113(2):342-7. PubMed ID: 24220281
    [Abstract] [Full Text] [Related]

  • 18. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
    Wöhrle J, Gonska B, Rodewald C, Trepte U, Koch S, Scharnbeck D, Seeger J, Markovic S, Rottbauer W.
    Int J Cardiol; 2015 Sep 15; 195():171-5. PubMed ID: 26043152
    [Abstract] [Full Text] [Related]

  • 19. Short-Term and Long-Term Outcomes of Patients Undergoing Urgent Transcatheter Aortic Valve Replacement Under a Minimalist Strategy.
    Ichibori Y, Li J, Patel T, Lipinski J, Ladas T, Saric P, Kobe D, Tsushima T, Peters M, Patel S, Davis A, Markowitz AH, Bezerra HG, Costa MA, Kalra A, Attizzani GF.
    J Invasive Cardiol; 2019 Feb 15; 31(2):E30-E36. PubMed ID: 30700628
    [Abstract] [Full Text] [Related]

  • 20. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG, Doshi D, Mack MJ, Makkar R, Smith CR, Pichard AD, Kodali S, Kapadia S, Miller DC, Babaliaros V, Thourani V, Herrmann HC, Bodenhamer M, Whisenant BK, Ramee S, Maniar H, Kereiakes D, Xu K, Jaber WA, Menon V, Tuzcu EM, Wood D, Svensson LG, Leon MB.
    JACC Cardiovasc Interv; 2015 Dec 21; 8(14):1797-806. PubMed ID: 26718510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.